EFX vs UCFI
EFX: A leading global data and analytics provider utilizing cloud-native AI to deliver high-value consumer insights, verification, and risk management solutions. UCFI: A China-based provider of grain-based, biotech-enhanced health foods currently facing significant regulatory challenges and a Nasdaq trading suspension.
Side-by-side fundamentals
| Metric | EFX | UCFI | Edge |
|---|---|---|---|
| Price as of 2026-10-26 close | $178.56 | $5.51 | |
| Market cap | $20.9B | $288M | |
| P/E as of 2026-10-26 | 28.89 | n/a | |
| Net margin FY2025, SEC XBRL | +10.9% | n/a | |
| Operating margin FY2025, SEC XBRL | +18.0% | n/a | |
| ROE FY2025, SEC XBRL | +14.3% | n/a | |
| ROA | +5.6% | +1.9% | EFX higher |
| Debt / equity | 1.16 | 0.13 | UCFI lower |
| Revenue growth (YoY) FY2025, SEC XBRL | +6.9% | n/a | |
| Revenue CAGR (3y) SEC XBRL | +5.8% | n/a | |
| Dividend yield as of 2026-09-03 | +1.4% | n/a | |
| Dividend streak (yrs) SEC XBRL | 18 | 0 | EFX higher |
| Beta as of 2026-09-03 | 0.92 | 0.06 | |
| 1-year return as of 2026-10-26 close | -23.6% | +0.0% | UCFI higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-26.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.